News
HC Wainwright & Co. Reiterates Buy on VYNE Therapeutics, Maintains $5.75 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Recap: VYNE Therapeutics Q4 Earnings
29 Feb 24
Earnings
VYNE Therapeutics Q4 Adjusted EPS $(0.18) Beats $(0.50) Estimate, Sales $76.00K Miss $150.00K Estimate
29 Feb 24
Earnings, News
VYNE Therapeutics To Present Results Of Phase 1b Trial For VYN201 At 2024 Global Vitiligo Foundation Annual Scientific Symposium
27 Feb 24
Biotech, News, General
Top 4 Health Care Stocks That May Rocket Higher In Q1
16 Jan 24
Long Ideas, News, Penny Stocks, Pre-Market Outlook, Markets, Trading Ideas
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
11 Jan 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
VYNE Therapeutics Announces Biomarker Data From Phase 1b Trial Of VYN201 For Treatment Of Vitiligo
10 Jan 24
Biotech, News, General